HistoSonics

HistoSonics, located in Ann Arbor, MI, is at the forefront of developing a groundbreaking non-invasive sonic beam therapy platform using histotripsy technology. This innovative treatment approach specifically targets and mechanically destroys liver tumors at a sub-cellular level, thereby offering a promising option for patients with unresectable tumors.

Committed to advancing the science of histotripsy, HistoSonics aims to deliver meaningful benefits for both physicians and patients worldwide. Through extensive clinical trials and a focus on education, the company amplifies its mission to transform cancer treatment while adhering to safety standards and physician training requirements.

Generated from the website